Literature DB >> 11834396

Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

Garry Welch1, Katie Weinger, Michael J Barry.   

Abstract

OBJECTIVES: To estimate the magnitude of the quality-of-life impact of lower urinary tract symptom (LUTS) severity using a large (n = 8406) sample of U.S. men participating in the Health Professionals Follow-up Study.
METHODS: Multiple regression modeling was used to estimate the relative quality-of-life burden of different levels of LUTS severity (defined using the American Urological Association Symptom Index as none-mild symptoms, 0 to 7; low moderate, 8 to 14; high moderate, 15 to 19; and severe, 20 to 35) and to compare these with age-matched U.S. male norms. A standardized and validated measure of both LUTS severity (the American Urological Association Symptom Index) and a widely used, standardized, multidimensional measure of quality of life (Short Form 36) were used. In addition, the relative impact of severe LUTS on the quality of life was compared with that experienced for other chronic illness conditions (diabetes, angina, hypertension, gout).
RESULTS: The results showed that high-moderate LUTS was associated with small to moderate deficits in anxious and depressed mood and poorer role functioning related to emotional problems arising from illness. Severe LUTS was associated with additional quality-of-life deficits related to vitality and the ability to work and carry out daily tasks as a result of illness. Comparisons of the severe LUTS patient group with four other chronic illness groups showed vitality/energy, in particular, but also role functioning and depressed and anxious feelings, to be poorer in the severe LUTS group.
CONCLUSIONS: Men with high-moderate and severe LUTS identified in a large U.S. cohort have a poorer health status in several important quality-of-life dimensions. The detection and effective treatment of LUTS may substantially improve the health status for these men in these dimensions.

Entities:  

Mesh:

Year:  2002        PMID: 11834396     DOI: 10.1016/s0090-4295(01)01506-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  56 in total

1.  How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?

Authors:  J Haltbakk; B R Hanestad; S Hunskaar
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

2.  Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.

Authors:  Philip M Ullrich; Susan K Lutgendorf; Karl J Kreder
Journal:  Urology       Date:  2007-09       Impact factor: 2.649

Review 3.  Benign prostatic hyperplasia. Part 1--diagnosis.

Authors:  Timothy J Wilt; James N'Dow
Journal:  BMJ       Date:  2008-01-19

4.  Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Zalmai Hakimi; Mike Herdman; Marco Pavesi; Nancy Devlin; Jameel Nazir; Chris Hoyle; Isaac A O Odeyemi
Journal:  Qual Life Res       Date:  2016-11-28       Impact factor: 4.147

5.  Partners agree that the treatment of LUTS reduces patients' bother and improves their quality of life: prospective 12 years follow-up study.

Authors:  Said Fadel Mishriki; Samuel J S Grimsley; Ghulam Nabi; Nicholas Paul Cohen
Journal:  World J Urol       Date:  2009-07-24       Impact factor: 4.226

6.  The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?

Authors:  Muhammet İhsan Karaman; Zülfü Sertkaya; Orhan Koca; Mehmet Akyüz; Mustafa Güneş; Metin İshak Öztürk
Journal:  Turk J Urol       Date:  2014-03

7.  Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey.

Authors:  Varant Kupelian; Raymond C Rosen; Carol L Link; Kevin T McVary; Lalitha Padmanabhan Aiyer; Patrick Mollon; Steven A Kaplan; John B McKinlay
Journal:  J Urol       Date:  2008-12-16       Impact factor: 7.450

8.  Quality of life in women with lipoedema: a contextual behavioral approach.

Authors:  Joanna E Dudek; Wojciech Białaszek; Paweł Ostaszewski
Journal:  Qual Life Res       Date:  2015-07-28       Impact factor: 4.147

Review 9.  Measurement of benign prostatic hyperplasia treatment effects on male sexual function.

Authors:  T A Skolarus; J T Wei
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

Review 10.  Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?

Authors:  Wesley Baas; Tobias S Köhler
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.